Macrophages are the first-line host defense where the invading Mycobacterium 25 tuberculosis (Mtb) encounters. It has been recently reported that host aerobic glycolysis 26 was elevated post the infection by a couple of virulent mycobacterial species. However, 27 whether this metabolic transition is required for host defense against intracellular 28 pathogens and the underlying mechanisms remain to be further investigated. By 29 analyzing carbon metabolism, we found that macrophages infected by M. marinum, a 30 surrogate mycobacterial specie to Mtb, showed a strong elevation of glycolysis. Next, 31 three glycolysis inhibitors were examined for their ability to inhibit mycobacterial 32 proliferation inside RAW264.7, a murine macrophage-like cell line. Among them, a 33 glucose analog, 2-deoxyglucose (2-DG) displayed a protective effect on assisting host 34 to resist mycobacterial infection, which was further validated in zebrafish-infection 35 model. The phagocytosis of M. marinum was significantly decreased in macrophages 36 pre-treated with 2-DG at concentrations of 0.5 and 1 mM, at which no inhibitory effect 37 was posed on M. marinum growth in vitro. Moreover, 2-DG pre-treatment exerted a 38 significant protective effect on zebrafish larvae to limit the proliferation of M. marinum, 39 and such effect was correlated to tumor necrosis factor alpha (TNF-α). On the contrary, 40 the 2-DG treatment post infection did not restrain proliferation of M. marinum in WT 41 zebrafish, and even accelerated bacterial replication in TNF-α -/zebrafish. Together, 42 modulation of glycolysis prior to infection boosts host immunity against M. marinum 43 infection, indicating a potential intervention strategy to control mycobacterial infection.
Hexokinase 2 (HK2) is the first enzyme in glycolysis which phosphorylates glucose to 136 produce glucose-6-phosphate (G6P). The glucose analogue 2-DG is phosphorylated by 137 HK2 to 2-DG-P but cannot be further metabolized, thus causes the metabolic block 8 138 which inhibits glycolysis [21] . Accordingly, we found that the expression of HK2 was 139 slightly increased in RAW cells post M. marinum infection, which was inhibited by 2-140 DG pre-treatment ( Fig 2D) . To determine cellular responses that 2-DG pretreatment might pose on, autophagy 145 and apoptosis, two pathways among major strategies by which macrophages combat 146 with M. marinum were investigated. Autophagy begins with the formation of double-147 membrane autophagosome, following with autophagolysosome development which 148 could be marked by Cyto-ID. Raw cells were treated 24h and 48h with 2-DG at 149 concentrations of 0, 1, 5 or 10 mM, followed by FACS analysis ( Fig 3A) . The treatment 150 of RAW cells with 1 mM 2-DG for 24h and 48h strongly induced cellular autophagy 151 ( Fig 3B) , which was further aggravated when higher concentration of 2-DG was applied. 
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The pre-treatment of 2-DG exerted a significant protective effect for host to resist M. 173 marinum proliferation lasting till 5 dpi, the end time point of experiments ( Fig 4B-4D) . 174 We next asked if such protective effects of 2-DG could be achieved through other 175 treatment methods. To our surprise, protective effects were not observed either when proliferation, the transcriptional level of several crucial cytokines related to TB 183 immunity including TNF-α, IL-6, IL-10 were examined in zebrafish larvae (data not 184 shown). Among them, the transcriptional level of TNF-α was significantly elevated in 185 2-DG pretreated zebrafish larvae on 28 hpf ( Fig 5A) . Consistently, 2-DG pretreatment 186 had also boosted the secretion of TNF-α in isolated mouse peritoneal macrophages 187 stimulated with LPS, compared to PBS as a mock ( Fig 5B) . was as follows: 0 min, 85%; 3 min, 30%; 12 min, 2%; 15 min, 2%; 16 min, 85%; 23 303 min, 85%. The mass spectrometer with a heated electrospray ionization source was 304 operated in negative modes, and the key parameters were same as described in [39] . 305 Data were analyzed using the Xcalibur software. 
